Source:http://linkedlifedata.com/resource/pubmed/id/21384386
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2011-3-8
|
| pubmed:abstractText |
Basal Cell Nevus syndrome (BCNS) is characterized by numerous basal cell carcinomas (BCCs). Multiple treatments with the pulsed dye laser (PDL) have been shown, in small studies, to be effective for the treatment of superficial and nodular BCCs. Like PDL, the alexandrite laser can be vessel-selective, but has the added advantage of deeper tissue penetration. We evaluated the utility of the alexandrite laser in reducing the tumor burden in BCNS with a single treatment.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
1096-9101
|
| pubmed:author | |
| pubmed:copyrightInfo |
Copyright © 2011 Wiley-Liss, Inc.
|
| pubmed:issnType |
Electronic
|
| pubmed:volume |
43
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
68-71
|
| pubmed:meshHeading |
pubmed-meshheading:21384386-Basal Cell Nevus Syndrome,
pubmed-meshheading:21384386-Humans,
pubmed-meshheading:21384386-Lasers, Solid-State,
pubmed-meshheading:21384386-Male,
pubmed-meshheading:21384386-Middle Aged,
pubmed-meshheading:21384386-Skin Neoplasms,
pubmed-meshheading:21384386-Treatment Outcome,
pubmed-meshheading:21384386-Tumor Burden
|
| pubmed:year |
2011
|
| pubmed:articleTitle |
755?nm alexandrite laser for the reduction of tumor burden in basal cell Nevus syndrome.
|
| pubmed:affiliation |
Department of Dermatology & Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA. omar.ibrahimi@gmail.com
|
| pubmed:publicationType |
Journal Article,
Review,
Case Reports,
Research Support, Non-U.S. Gov't
|